Tranexamic acid is considered safe for cosmetic use at concentrations up to 5% in leave-on and rinse-off formats based on published in-vitro, in-vivo, and clinical data. It works by inhibiting plasminogen activator in keratinocytes, which in turn reduces melanin transfer to the skin surface — making it an effective brightening active for hyperpigmentation, uneven skin tone, and post-inflammatory marks from acne or ingrown hairs, conditions that are common on the body as well as the face.
In a rinse-off scrub format, effective concentrations typically range from 2% to 5%. Lower concentrations (1–2%) are sometimes used in combination formulas where TXA is stacked with niacinamide, alpha-arbutin, or vitamin C derivatives to achieve a synergistic brightening effect. At 3–5%, TXA alone provides a meaningful dose in a scrub context, though some formulators argue that leave-on products deliver more sustained exposure to the skin.
From a safety and compatibility standpoint, TXA is well-tolerated even on sensitive skin at standard concentrations. It does not carry the irritation risk associated with kojic acid or the regulatory burden of hydroquinone, which is banned in cosmetics in the EU and Canada. It is not a known photosensitizer, which is an advantage for a body product used before sun exposure.
Formulation pH is critical. TXA is most stable and most efficacious at pH 5.5–6.5, which aligns well with the skin's natural acid mantle. Formulators must verify that the physical exfoliant and any fragrance or botanical extracts in the base do not shift pH out of this range over shelf life.
One compatibility consideration is physical exfoliant particle size. Jagged exfoliants like walnut shell can create micro-tears in skin that temporarily increase permeation of any active, including TXA. This is generally not a safety concern at cosmetic concentrations, but some brands opt for smooth spherical exfoliants (jojoba beads, sugar) to control permeation more predictably and to avoid the regulatory scrutiny that has followed walnut shell scrubs in the EU.
For regulatory purposes in the U.S., TXA at standard cosmetic concentrations is classified as a cosmetic ingredient, not a drug. Brands must avoid disease claims ("treats melasma") and stick to appearance claims ("visibly brighter, more even-toned skin"). In the EU, TXA is permitted under Regulation (EC) No 1223/2009 and does not appear on Annexes II, III, IV, or V as a restricted or prohibited substance at typical use levels, making compliance straightforward with a proper CPSR in place.
Ingredients in this answer: Tranexamic Acid · Alpha-Arbutin · Niacinamide · Kojic Acid
Read the full guide on Private Label Tranexamic Acid Body Scrub Manufacturer Low MOQ →